Altos Labs

company

About

Altos Labs focuses on cellular rejuvenation programming to restore cell health and resilience, to reverse disease to transform medicine.

  • 101 - 250

Details

Last Funding Type
Series A
Last Funding Money Raised
$3B
Industries
Biopharma,Biotechnology
Founded date
Jan 1, 2021
Number Of Employee
101 - 250
Operating Status
Active

Altos Labs is a new biotechnology company focused on cellular rejuvenation programming to restore cell health and resilience, with the goal of reversing disease to transform medicine.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$3B
Altos Labs has raised a total of $3B in funding over 2 rounds. Their latest funding was raised on Jan 1, 2021 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2021 Series A $3B 1 Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Altos Labs has made 2 investments. Their most recent investment was on Oct 10, 2022, when Ludenso raised $1M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 10, 2022 Ludenso
Seed $1M Augmented Reality
Feb 20, 2020 Ludenso
Seed Augmented Reality

Investors

Number of Lead Investors
Number of Investors
1
Altos Labs is funded by 1 investors. ARCH Venture Partners are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Series A